Viewing Study NCT01026051

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:54 PM
Ignite Modification Date: 2026-01-05 @ 5:31 PM
Study NCT ID: NCT01026051
Status: TERMINATED
Last Update Posted: 2012-05-15
First Post: 2009-12-03
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety, Immune and Tumor Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma
Sponsor: Mannkind Corporation
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Stage III Melanoma View
None Stage IV Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cancer Vaccine, Immunotherapy, Melanoma View